We use essential cookies and third-party cookies for content.

Arizona Tribune - Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

Arizona Tribune
×
NYSE - LSE
CMSC -0.53% 21.93 $
NGG -0.49% 83.01 $
GSK 1.16% 52.5 $
CMSD -0.73% 21.77 $
VOD 0.22% 13.89 $
BCE -1.22% 22.92 $
RYCEF 2.12% 18.39 $
RIO -1.46% 93.74 $
RBGPF 5.69% 65 $
BTI 0.45% 62.76 $
RELX 1.34% 31.34 $
BCC 1.56% 81.02 $
AZN 1.45% 188.41 $
JRI 1.64% 12.79 $
BP -1.59% 37.13 $
Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

BOULEVARD 10.04.2025

CAMBRIDGE, MA / ACCESS Newswire / April 10, 2025 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 1, 2025 to report its first quarter 2025 financial results, and provide a corporate update.

Text size:

A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.

The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Media Contacts

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]

SOURCE: Moderna, Inc.



View the original press release on ACCESS Newswire

O.Ortiz--AT

Featured

'We need help': Venezuelans furious at slow official response to quakes

'We need help': Venezuelans furious at slow official response to quakes
Venezuela quakes kill almost 1,500, with millions more in need

Venezuela quakes kill almost 1,500, with millions more in need
Venezuela earthquake deaths near 1,000, with millions more in need

Venezuela earthquake deaths near 1,000, with millions more in need
Newborn baby rescued from rubble of Venezuela quake

Newborn baby rescued from rubble of Venezuela quake